Argos Therapeutics, Inc. EBITDA 2014-2018 | ARGSQ
Argos Therapeutics, Inc. ebitda from 2014 to 2018. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Argos Therapeutics, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2017 | $-61 |
| 2016 | $-51 |
| 2015 | $-72 |
| 2014 | $-51 |
| 2013 | $-24 |
| 2012 | $-16 |
| 2011 | $-8 |
| Argos Therapeutics, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2018-09-30 | $-4 |
| 2018-06-30 | $-6 |
| 2018-03-31 | $-2 |
| 2017-12-31 | $-2 |
| 2017-09-30 | $-8 |
| 2017-06-30 | $-8 |
| 2017-03-31 | $-44 |
| 2016-12-31 | $-15 |
| 2016-09-30 | $-12 |
| 2016-06-30 | $-12 |
| 2016-03-31 | $-12 |
| 2015-12-31 | $-17 |
| 2015-09-30 | $-19 |
| 2015-06-30 | $-19 |
| 2015-03-31 | $-17 |
| 2014-12-31 | $-15 |
| 2014-09-30 | $-15 |
| 2014-06-30 | $-12 |
| 2014-03-31 | $-9 |
| 2013-12-31 | $-8 |
| 2013-09-30 | $-6 |
| 2013-06-30 | $-6 |
| 2013-03-31 | $-5 |
